Association of Meier-Gorlin and microcephalic osteodysplastic primordial dwarfism type II clinical features in an

Quentin Sabbagh1, Mylène Tharreau2, Camille Cenni2

  • 1Montpellier University, Service de Génétique Clinique, Centre de Compétence Maladies Osseuses Constitutionnelles, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Insights

Primary microcephaly type 3 (MCPH3), caused by CDK5RAP2 gene variants, presents new skeletal features. This expands the known clinical spectrum of this rare genetic disorder.

Area of Science:

  • Genetics
  • Developmental Biology
  • Clinical Medicine

Background:

  • Autosomal recessive primary microcephaly type 3 (MCPH3) is a rare genetic disorder.
  • It is characterized by severe microcephaly, neurodevelopmental delay, sensorineural hearing loss, skin pigmentation abnormalities, and ocular defects.
  • MCPH3 is caused by pathogenic variants in the CDK5RAP2 gene, which plays a role in centrosome function.

Observation:

  • This study describes a 10-year-old girl with a biallelic exonic frameshift variant in CDK5RAP2.
  • The patient exhibited previously unreported features, including skeletal abnormalities typically associated with Meier-Gorlin syndrome and microcephalic osteodysplastic primordial dwarfism type II (MOPDII).

Findings:

  • The findings expand the known clinical phenotype of MCPH3.
  • This case highlights that MCPH3 can present with skeletal dysplasia, mimicking other primordial dwarfism syndromes.
  • The study emphasizes the centrosomal basis of this form of primary microcephaly.

Implications:

  • The study underscores the importance of comprehensive skeletal defect screening in individuals diagnosed with MCPH3.
  • Recognizing this expanded phenotype can lead to earlier and more accurate diagnosis.
  • Further research into CDK5RAP2 function may reveal new therapeutic targets for microcephaly and related disorders.